RESMED INC — Director's Dealing 2010

Feb 17, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-02-12

Reporting Person: Jacobsen Stein (COO, Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-02-12	ResMed Common Stock	M	12000	$38.50	Acquired	14376.063	Direct
2010-02-12	ResMed Common Stock	S	12000	$55.6476	Disposed	2376.063	Direct
2010-02-12	ResMed Common Stock	M	17500	$31.04	Acquired	19876.063	Direct
2010-02-12	ResMed Common Stock	S	17500	$55.6675	Disposed	2376.063	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-12	ResMed Common Stock Options	$38.50	M	12000	Disposed	2016-02-03	ResMed Common Stock (12000)	Direct
2010-02-12	ResMed Common Stock Options	$31.04	M	17500	Disposed	2015-11-20	ResMed Common Stock (17500)	Direct

Footnotes

F1: Represents first date options became exercisable.

F2: This transaction was executed in multiple trades at prices rangining from $55.56 to $55.74. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: This transaction was executed in multiple trades at prices rangining from $55.53 to $55.74. The price reported reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Previous reports aggregated all beneficially owned derivative securities following the reported transaction. This report includes only beneficially owned derivative securities of the same class as those disposed of in this trade, meaning those that have the same grant date and exercise price.